International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Special Issue 6
Original Research Article
Surgical Outcomes and Complications of Laparoscopic Hysterectomy for Endometriosis: A Retrospective Cohort Study
Published
Dec. 28, 2024
Abstract

Objective: This study aimed to evaluate the operative outcomes and postoperative complications of laparoscopic hysterectomy (LH) for endometriosis. Methods: A retrospective cohort analysis was conducted on 30 patients who underwent LH for endometriosis between May 2023 and May 2024 at the Department of Obstetrics and Gynecology, KVG Medical College and Hospital, Sullia. Inclusion criteria encompassed radiologically diagnosed endometriosis and procedures such as endometrioma enucleation or ureterolysis, while bowel or urinary tract surgeries were excluded. Data on demographics, surgical details, and complications (Clavien-Dindo classification) were extracted from medical records. Statistical analysis included chisquare tests, logistic regression, and descriptive statistics. Results: The median age was 44 years (range: 28–54), with a median operative time of 113 minutes (range: 27–365) and blood loss of 100 mL (range: 10–2000). Intraoperative complications occurred in 3.0% of cases, while postoperative complications were observed in 13.8%, predominantly Clavien-Dindo grade 1–2 (9.8%). Major complications (grade ≥2) were inversely associated with age (OR 0.94, 95% CI 0.90–0.99) and positively correlated with previous endometriosis surgery (OR 1.62, 95% CI 1.01–2.60). Preoperative medical treatment reduced complication risk (OR 0.50, 95% CI 0.31–0.81). Conclusion: LH for endometriosis is associated with low intraoperative morbidity but notable postoperative complications, influenced by age, prior surgery, and medical therapy. These findings underscore the importance of preoperative counseling and optimization.

Recommended Articles
Loading Image...
Volume-5, Special Issue 6
Citations
769 Views
285 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved